Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.35 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1230110 | 0.97 | TSHR (0.40) | TSHRPLA2G1BPLA2G2ASIGMAR1TDP1 | |
| Bromide SCHEMBL28878835 | 0.95 | TSHR (0.38) | TSHRPLA2G1BPLA2G2ASIGMAR1TDP1 | |
| SCHEMBL19368129 | 0.85 | TSHR (0.35) | TSHRPLA2G1BPLA2G2A | |
| SCHEMBL20996679 | 0.83 | CYP1A2 (0.45) | TSHRSIGMAR1TDP1ALDH1A1 | |
| SCHEMBL81187 | 0.83 | TSHR (0.39) | TSHRTDP1ALDH1A1 | |
| SCHEMBL557630 | 0.82 | SIGMAR1 (0.41) | TSHRPLA2G1BPLA2G2ASIGMAR1NPSR1 | |
| SCHEMBL20996677 | 0.80 | CYP1A2 (0.34) | TSHRPLA2G1BPLA2G2ASIGMAR1TDP1 | |
| SCHEMBL4908461 | 0.79 | PLA2G1B (0.40) | PLA2G1BPLA2G2ASIGMAR1NPSR1 | |
| SCHEMBL1230885 | 0.79 | TSHR (0.38) | TSHRTDP1ALDH1A1 | |
| SCHEMBL29171486 | 0.78 | SIGMAR1 (0.47) | TSHRPLA2G1BPLA2G2ASIGMAR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7910078-B2 | using an aminoalcohol derived from 4-amino-2-butanol, which have a higher CO2 absorption capacity; global warming; e.g. 4-(diethylamino)-2-butanol or 4-(piperidino)-2-butanol | UNIVERSITY OF REGINA (CA) | 2011-03-22 | — | — | US | disclosed |
| US-20080050296-A1 | METHOD OF CAPTURING CARBON DIOXIDE FROM GAS STREAMS | UNIVERSITY OF REGINA (CA) | 2008-02-28 | — | — | US | disclosed |
| WO-2008022437-A1 | METHOD FOR CAPTURING CARBON DIOXIDE FROM GAS STREAMS | UNIVERSITY OF REGINA (CA) | 2008-02-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080050296-A1 | METHOD OF CAPTURING CARBON DIOXIDE FROM GAS STREAMS | ADH1C, ADH5, ADH1A | TSHR 2907/4885PLA2G1B 1213/4885PLA2G2A 1922/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.